MoneyWorks4Me

Glenmark Pharmaceuticals informs about press release

06 Sep 2016 Evaluate

Glenmark Pharmaceuticals has informed about a Press Release dated September 06, 2016 titled ‘Glenmark announces the Discovery and Initiation of IND-enabling studies of a novel Bispecific Monoclonal Antibody targeting EGFR’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..